Question about Cervical Cancer?

About 2 year ago, I was told I had displasia, and they went in and frooze it. Now I was told I have HPV. I only have about 6 months before I am no longer able to get the shot for HPV because of my age. I really don't want to get it because it is so new. My aunt also died of cervical cancer. What are my chances of getting it, with my family history and my history?

you can still get the shot for hpv if you already have been told you have hpv because there are many many different strands of it and you won't know which one you have...and the shot could protect you from the strands you don't have....you should just go to the doctor regularly for pap smears...as long as they catch the precancer cells before they turn into cancer you'll be good....i've had the precancer cells twice on my cervix and had to get surgery twice...just keep up with you pap smears (they made me go every 3 months for a year) good luck

If you already have HPV I am not sure if you can even get the shot. You need to talk to your doctor about all of this. Also be sure that your partners all know that you have HPV and be sure to use protection etc.
I have had displasia and precancer, the doctor did a procedure called the cone, and it really helped remove these cells. I now go every 6 months for checkups. Ask your doctor about the CONE, there is a long name for this but I cannot think of it right now. Also, talk about the shot...Good Luck
Cervical Cancer can't occur without one of the 15 or so high risk HPV types.

Dysplasia is due to HPV.

Did you have a recent Pap that found abnormal cells and a positive HPV test?

HPV can reoccur after treatment and we can acquire new HPV types with new sex partners.

The approved HPV vaccine from Merck provides protect to two high risk HPV types and two low risk HPV types. It will not treat the HPV types we have. There is theory that the vaccine may help our body build antibodies to the HPV type we have but clinical studies thus far have not proved this. Gardasil has been approved for use even when you have been diagnosed with dysplasia or abnroal cells or with genital warts.

Genetic may play a part in the viruses鈥?progression to a cancer. Your aunt death due to cervical cancer was first because she acquired second because her body could not fight the virus as it should, and because abnormal cells were not treated aggressively as they should. I am not sure of her age but she could have also had glandular cell changes when are more aggressive and faster to progress than squamous cells.

You play a big part in your viruses progress...you can limit your number of sex partners, always use condoms and do the other little things that help our body's fight cancer also be diligent with your Pap test and HPV test. Pap tests are good but they can miss abnormal cell changes.

If you have insurance that covers the vaccine then do your research and talk with your doctor about getting the vaccine.

There is another HPV vaccine that has asked the FDA for approval. It looks like this vaccine has been studied more than Merck鈥檚 vaccine and has been studied in women to age 55. GSK vaccine Cervarix is only for two high risk HPV types 16 and 18. We don't know when GSK will seek the FDA approval and we don't know how the GSK vaccine will be recommend to be used. It will probably be approved in the next few months.

Do you research talk with your doctor but ultimately it will be your decision regarding getting the Meck vaccine or waiting to learn more about GSK vaccine.

Good luck.

GlaxoSmithKline (NYSE: GSK) announced the company has submitted a
Biologics License Application (BLA) for CERVARIX (human
papillomavirus vaccine, AS04 adjuvant-adsorbed), its cervical cancer
candidate vaccine, to the U.S. Food and Drug Administration (FDA). If
licensed, the vaccine will be indicated for the prevention of
cervical cancer and precancerous lesions associated with the most
common cancer-causing human papillomavirus types. For this candidate
vaccine, GSK selected a novel proprietary adjuvant system called
AS04, intended to enhance immune response and increase duration of
protection.

The BLA for the GSK cervical cancer candidate vaccine includes data
from clinical trials in almost 30,000 females 10 to 55 years of age
and reflects an ethnically diverse population. The submission also
contains data from the largest Phase III cervical cancer vaccine
efficacy trial to date, which was conducted around the world in more
than 18,000 females 15 to 25 years of age.